Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Hepatitis C virus (HCV), non-structural 5A (NS5A), and non-structural 5B (NS5B) resistance-associated substitutions (RASs) are the main causes of failure to direct-acting antiviral agents (DAAs). NS5A and NS5B RASs can occur in patients with HCV infection naturally and before exposure to DAAs.
Objectives: This study aimed to evaluate naturally-occurring NS5A and NS5B RASs in Iranian patients with HCV genotype 1a (HCV-1a) and -3a infections.
Methods: In this cross-sectional study, viral RNA was extracted from serum specimens. NS5A and NS5B regions were amplified using RT-PCR followed by DNA sequencing. The results of nucleotide sequences were aligned against reference sequences of HCV-1a and -3a and the amino acid substitutions were analyzed using geno2pheno [hcv] web application.
Results: Among 135 patients with hepatitis C, NS5A amino acid substitutions/RASs were identified in 26.4% and 15.9% of patients with HCV-1a and -3a infections, respectively. The identified amino acid substitutions/RASs in the NS5A region of patients with HCV-1a infection were M28T/V/I 11.1%, Q30R/H 4.2%, L31M 1.4%, and H58Y/P/C/D/Q/S/T 16.7%. Y93H substitution was not found in HCV-1a sequences. In patients with HCV-3a infection, NS5A amino acid substitutions/RASs were A30T/K 9.5%, L31F 1.6%, P58S/T/C 3.2%, Y93H 3.2%, and Y93N 3.2%. No resistance substitutions were identified in NS5B sequences from patients with HCV-1a and -3a infections.
Conclusion: In this study, baseline amino acid substitutions/RASs were only identified in the NS5A region in Iranian patients with HCV-1a and -3a infections, and the prevalence of these amino acid substitutions/RASs were in accordance with similar studies. There were no RASs in the HCV-1a and -3a NS5B region.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876467 | PMC |
| http://dx.doi.org/10.3389/fmicb.2020.617375 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Risk Factors Associated with Hepatitis C Subtypes and the Evolutionary History of Subtype 1a in Mexico.
Viruses
August 2024
Department of Genomic Medicine in Hepatology, Civil Hospital of Guadalajara, "Fray Antonio Alcalde", Guadalajara 44280, Jalisco, Mexico.
Article Synopsis
- - The study investigates the risk factors for Hepatitis C Virus (HCV) transmission, focusing on subtype 1a in Mexico, where it was found to be the most prevalent (58.5%) among the 260 infected adults analyzed between 2014 and 2018.
- - Significant risk factors associated with HCV transmission include intravenous drug use and tattoos for subtypes 1a and 3a, while hemodialysis and blood transfusions are linked to subtype 1b.
- - The research suggests subtype 1a was introduced to Mexico in 1976, with notable increases in cases from 1998 to 2006, highlighting the need for tailored prevention strategies like improving medical training, reducing
Prevalence of Naturally Occurring Resistance Associated Substitutions in NS3/4AProtease Inhibitors in Iranian HCV/HIV Infected Patients.
Curr HIV Res
May 2022
Clinical Research Dept., Pasteur Institute of Iran, Tehran, Iran.
Article Synopsis
- Hepatitis C virus (HCV) can evade the immune system and has developed naturally occurring resistance substitutions (RASs) that complicate treatment with direct acting antivirals (DAAs), which are generally effective but face resistance issues.
- This study examined 120 patients co-infected with HCV and HIV to identify the prevalence of NS3/4A RASs using PCR and Sanger sequencing techniques.
- Findings revealed low RAS prevalence (5%) in HCV subtype 1a, but the presence of double and triple mutations suggests the need for testing for mutations before starting DAA treatment, highlighting the importance of further research in larger populations.
Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection.
Front Microbiol
January 2021
Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran.
Article Synopsis
- Hepatitis C virus (HCV) resistance-associated substitutions (RASs) in the NS5A and NS5B regions are major factors in failed treatment with direct-acting antiviral agents (DAAs), and can occur before treatment begins.
- This study focused on identifying these NS5A and NS5B RASs in Iranian patients with HCV genotype 1a and 3a infections, using serum samples and advanced DNA sequencing techniques.
- Results showed that NS5A mutations were present in 26.4% of HCV-1a and 15.9% of HCV-3a patients, with no RASs found in the NS5B sequences, aligning with findings from other studies.
Prevalence of hepatitis C virus among HIV-infected patients.
Iran J Microbiol
April 2020
Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Article Synopsis
- The study focused on the co-infection rates of Hepatitis C virus (HCV) among individuals living with Human Immunodeficiency Virus (HIV) in Ahvaz city, Iran, emphasizing the health risks associated with such co-infections.
- Out of 78 HIV positive individuals tested, 32.05% were found to be positive for HCV antibodies, with 24.35% of those also testing positive for HCV RNA.
- The dominant HCV genotype identified was 3a, primarily found in male injecting drug users, highlighting the need for regular monitoring of HCV in HIV-infected individuals.
Pre-existing resistance associated polymorphisms to NS3 protease inhibitors in treatment naïve HCV positive Pakistani patients.
PLoS One
July 2020
Department of Biological Sciences, International Islamic University, Islamabad, Pakistan.
Chronic Hepatitis C Virus (HCV) infection is still a major health issue especially in endemic areas where fewer direct-acting virals (DAAs) are treatment options. Some HCV variants are associated with resistance and it reduces DAAs success where pre-existing variants prevail. In this study, we investigated resistance-associated polymorphisms (RAPs) in the HCV NS3 region from DAAs naïve Pakistani patients.
View Article and Find Full Text PDF